The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been filed against Hims & Hers Health, Inc. ("Hims & ...

Novo Nordisk's legal actions against U.S. pharmacies over compounded copies of its drug Wegovy exclude Hims & Hers, a ...

PNC Financial Services Group Inc. lifted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 123.8% ...

Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.

The fear gauge CBOE Volatility Index (VIX) was down 8.6% to 15.15. A total of 16.2 billion shares were traded on Friday, ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short ...

Gilead Sciences Inc.’s (GILD) shares jumped 8.3% after posting second-quarter 2025 adjusted earnings of $2.01 per share, ...

Detailed price information for Rackspace Technology Inc (RXT-Q) from The Globe and Mail including charting and trades.

In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug ...